The hepatitis E virus (HEV) was initially thought to exclusively cause acute hepatitis.
However, the first diagnosis of chronic hepatitis E in transplant recipients in 2008 profoundly …

Each hepatitis virus—Hepatitis A, B, C, D, E, and G—poses a distinct scenario to the patient
and clinician alike. Since the discovery of each virus, extensive knowledge regarding …

Abstract Background Hepatitis E virus (HEV) variants belonging to Orthohepevirus species A
(HEV-A) are the primary cause of human hepatitis E. However, we previously reported that …

Hepatitis E virus (HEV) is a major cause of viral hepatitis globally. There is growing concern
about transfusion-transmitted HEV (TT-HEV) as an emerging global health problem. HEV …

Background Although acute hepatitis E is not fatal in healthy individuals, it is unclear
whether hepatitis E superinfection increases the mortality in patients with pre-existing liver …

Background and Aims Immunocompromised patients are at risk of chronic hepatitis E which
can be acquired by blood transfusions. Currently, screening of blood donors (BDs) for HEV …

Hepatitis E virus (HEV) is the major cause of acute viral hepatitis in several countries in
Europe. HEV is acquired mainly by consumption of contaminated pork but can also be …

Background Therapeutic plasma exchange (TPE) and immunoadsorption (IA) are first or
second line treatment options in patients with neurological autoimmune diseases, including …

Liver transplantation (LT) is a life-saving surgical procedure and the current standard of care
for most patients with end stage liver disease. With improvements in organ preservation …

In England, all blood donations are screened in pools of 24 by nucleic acid test (NAT) for
hepatitis E virus (HEV) RNA. During 2016–2020, this screening successfully identified and …